The final installment of the OHSU-PSU Gun Violence as a Public Health Issue forum series explored the role of the business, government and community in helping curb gun violence.
The Office of Cancer Clinical Proteomics Research (OCCPR) at the National Cancer Institute (NCI) announced the institutes that will comprise the Proteogenomic Translational Research Centers, a group created to collaborate with NCI-sponsored clinical trials.
After review, OHSU is opposed to the U.S. Senate’s Better Health Care Reconciliation Act and believes it offers no significant improvements over the bill passed in the House earlier this year.
Today the OHSU Knight Cancer Institute announced that internationally renowned bioengineering and technology expert Mike Heller, Ph.D., will join the institute’s Cancer Early Detection Advanced Research Center, or CEDAR, to lead its technology efforts.
A study of more than 500 cancer survivors found that many years after completing treatment, nearly half of women cancer survivors continued to experience chemotherapy-induced peripheral neuropathy, CIPN.
A first-of-its-kind collaboration between hospital and regional insurance providers provides community-based interventions to support youth whose medical needs are compounded by social problems.